| Reliability and validity of the mini international neuropsychiatric interview for children and adolescents (MINI-KID) DV Sheehan, KH Sheehan, RD Shytle, J Janavs, Y Bannon, JE Rogers, ... The Journal of clinical psychiatry 71 (3), 17393, 2010 | 1475 | 2010 |
| Cholinergic modulation of microglial activation by α7 nicotinic receptors RD Shytle, T Mori, K Townsend, M Vendrame, N Sun, J Zeng, J Ehrhart, ... Journal of neurochemistry 89 (2), 337-343, 2004 | 705 | 2004 |
| Green tea epigallocatechin-3-gallate (EGCG) reduces β-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice K Rezai-Zadeh, GW Arendash, H Hou, F Fernandez, M Jensen, ... Brain research 1214, 177-187, 2008 | 522 | 2008 |
| Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation J Ehrhart, D Obregon, T Mori, H Hou, N Sun, Y Bai, T Klein, F Fernandez, ... Journal of neuroinflammation 2, 1-13, 2005 | 444 | 2005 |
| Cocrystals of quercetin with improved solubility and oral bioavailability AJ Smith, P Kavuru, L Wojtas, MJ Zaworotko, RD Shytle Molecular pharmaceutics 8 (5), 1867-1876, 2011 | 402 | 2011 |
| Nicotinic acetylcholine receptors as targets for antidepressants RD Shytle, AA Silver, RJ Lukas, MB Newman, DV Sheehan, PR Sanberg Molecular psychiatry 7 (6), 525-535, 2002 | 334 | 2002 |
| Analysis of mecamylamine stereoisomers on human nicotinic receptor subtypes RL Papke, PR Sanberg, RD Shytle Journal of pharmacology and experimental therapeutics 297 (2), 646-656, 2001 | 315 | 2001 |
| Nanolipidic particles improve the bioavailability and α-secretase inducing ability of epigallocatechin-3-gallate (EGCG) for the treatment of Alzheimer's disease A Smith, B Giunta, PC Bickford, M Fountain, J Tan, RD Shytle International journal of pharmaceutics 389 (1-2), 207-212, 2010 | 297 | 2010 |
| Green tea epigallocatechin-3-gallate (EGCG) and other flavonoids reduce Alzheimer's amyloid-induced mitochondrial dysfunction N Dragicevic, A Smith, X Lin, F Yuan, N Copes, V Delic, J Tan, C Cao, ... Journal of Alzheimer's Disease 26 (3), 507-521, 2011 | 223 | 2011 |
| Apigenin and luteolin modulate microglial activation via inhibition of STAT1-induced CD40 expression K Rezai-Zadeh, J Ehrhart, Y Bai, PR Sanberg, P Bickford, J Tan, ... Journal of neuroinflammation 5, 1-10, 2008 | 214 | 2008 |
| Neuroprotective mechanisms of astaxanthin: a potential therapeutic role in preserving cognitive function in age and neurodegeneration B Grimmig, SH Kim, K Nash, PC Bickford, R Douglas Shytle Geroscience 39, 19-32, 2017 | 180 | 2017 |
| Flavonoid‐mediated presenilin‐1 phosphorylation reduces Alzheimer's disease β‐amyloid production K Rezai‐Zadeh, R Douglas Shytle, Y Bai, J Tian, H Hou, T Mori, J Zeng, ... Journal of cellular and molecular medicine 13 (3), 574-588, 2009 | 162 | 2009 |
| Nicotine's oxidative and antioxidant properties in CNS MB Newman, GW Arendash, RD Shytle, PC Bickford, T Tighe, ... Life sciences 71 (24), 2807-2820, 2002 | 151 | 2002 |
| Nicotine for the treatment of Tourette's syndrome PR Sanberg, AA Silver, RD Shytle, MK Philipp, DW Cahill, HM Fogelson, ... Pharmacology & therapeutics 74 (1), 21-25, 1997 | 148 | 1997 |
| Transdermal nicotine and haloperidol in Tourette's disorder: a double-blind placebo-controlled study AA Silver, D Shytle, MK Philipp, BJ Wilkinson, B McConville, PR Sanberg Journal of Clinical Psychiatry 62 (9), 707-714, 2001 | 144 | 2001 |
| Nicotinic antagonist augmentation of selective serotonin reuptake inhibitor-refractory major depressive disorder: a preliminary study TP George, KA Sacco, JC Vessicchio, AH Weinberger, RD Shytle Journal of clinical psychopharmacology 28 (3), 340-344, 2008 | 135 | 2008 |
| Antiretroviral medications disrupt microglial phagocytosis of β-amyloid and increase its production by neurons: implications for HIV-associated neurocognitive disorders B Giunta, J Ehrhart, DF Obregon, L Lam, L Le, JJ Jin, F Fernandez, J Tan, ... Molecular brain 4, 1-6, 2011 | 130 | 2011 |
| Mecamylamine: new therapeutic uses and toxicity/risk profile JM Young, RD Shytle, PR Sanberg, TP George Clinical therapeutics 23 (4), 532-565, 2001 | 130 | 2001 |
| Flavonoids, a prenatal prophylaxis via targeting JAK2/STAT3 signaling to oppose IL-6/MIA associated autism E Parker-Athill, D Luo, A Bailey, B Giunta, J Tian, RD Shytle, T Murphy, ... Journal of neuroimmunology 217 (1-2), 20-27, 2009 | 126 | 2009 |
| Nutraceuticals synergistically promote proliferation of human stem cells PC Bickford, J Tan, RD Shytle, CD Sanberg, N El-Badri, PR Sanberg Stem cells and development 15 (1), 118-123, 2006 | 119 | 2006 |
Paul R. SanbergUniv. of S. Florida Senior Vice President for Research, Innovation & Knowledge Enterprise; DistVerified email at usf.edu
